- Open Access
Effects of Lactobacillus rhamnosus GG supplementation on cow's milk allergy in a mouse model
© Thang et al; licensee BioMed Central Ltd. 2011
- Received: 2 June 2011
- Accepted: 6 December 2011
- Published: 6 December 2011
Cow's milk allergy (CMA) is one of the most prevalent human food-borne allergies, particularly in infants and young children from developed countries. Our study aims to evaluate the effects of Lactobacillus rhamnosus GG (LGG) administration on CMA development using whole cow's milk proteins (CMP) sensitized Balb/C mice by two different sensitization methods.
LGG supplemented mice were either sensitized orally with CMP and cholera toxin B-subunit (CTB) as adjuvant, or intraperitoneally (IP) with CMP but without the adjuvant. Mice were then orally challenged with CMP and allergic responses were accessed by monitoring hypersensitivity scores, measuring the levels of CMP-specific immunoglobulins (IgG1, IgG2a and IgG) and total IgE from sera, and cytokines (IL-4 and IFN-γ) from spleen lysates.
Sensitization to CMP was successful only in IP sensitized mice, but not in orally sensitized mice with CMP and CTB. Interestingly, LGG supplementation appeared to have reduced cow's milk allergy (CMA) in the IP group of mice, as indicated by lowered allergic responses.
Adjuvant-free IP sensitization with CMP was successful in inducing CMA in the Balb/C mice model. LGG supplementation favourably modulated immune reactions by shifting Th2-dominated trends toward Th1-dominated responses in CMP sensitized mice. Our results also suggest that oral sensitization by the co-administration of CMP and CTB, as adjuvant, might not be appropriate to induce CMA in mice.
- Lactobacillus Count
- Oral Sensitization
- Hypersensitivity Symptom
- Fecal Lactobacillus
Cow's milk allergy (CMA), an immunologically mediated reaction to cow's milk proteins , is one of the most prevalent human food-borne allergies, particularly in infants and young children. In North America, incidence of CMA is estimated at 2.5% in children and about 1% in adults with a 75% outgrowing rate at 16 years of age . Milk protein comprises a mixture of multiple proteins, including whey (such as β-lactoglobulin, α-lactalbumin and bovine serum albumin) and casein (such as α-S1-, α-S2-, β-, κ-, and γ-caseins) proteins. Hypersensitivity reactions may occur upon exposure to a single or multiple milk protein(s). Numerous attempts have been made to reduce or eliminate the allergenicity of milk proteins. Of these attempts, most have focussed on two approaches: to alter the structure and property of milk proteins through thermal treatments, biochemical processes (enzymatic digestion), irradiation  and high pressure treatments , and to modulate immune responses through sensitization and tolerance induction by means of controlled exposure to a specific allergen which is commonly referred to as specific immunotherapy . Nevertheless, total avoidance of cow's milk or its associated products still remains as the best remedy for CMA. Hypersensitivity to orally ingested food usually occurs upon failure to induce oral tolerance. Research with germ-free mice has indicated that the interaction between allergens and host's gut microbiota plays a crucial role in oral tolerance development  and in reducing secretions of allergen-specific antibodies . The gut microbiota is also reported to favour anti-allergenic reactions by mediating T-helper-1 (Th1) type of immunity  or inducing IL-10 and transforming growth factor-β (TGF-β) that suppresses T-helper-2 (Th2) type of immunity . Recently, delayed microbial exposure and/or reduced diversity of the gut microbiota among children have been associated with higher allergy incidences . This concept was first reported by Strachan  and later widely known as the 'hygiene hypothesis'. Interestingly, whereas the gut microbiota of allergic infants contained higher levels of Clostridia, intestinal Lactobacilli and Bifidobacteria were more predominant among healthy infants [12, 13]. Such findings have triggered considerable scientific interests in probiotics, particularly Lactobacilli and Bifidobacteria, for prevention or treatment of allergies among infants. The allergy reducing effects of probiotics against food allergens such as egg ovalbumin [14, 15] and whey proteins  have been demonstrated in mouse allergy models. But, to the best of our knowledge, probiotic effects of Lactobacillus rhamnosus GG (LGG) to reduce or control allergy to whole cow's milk protein (CMP) have not yet been reported in a mouse allergy model. We used the Balb/C mice model based on its similarity with the human immune system, particularly the Th1 and Th2 responses .
Oral sensitization is well recognized as an ideal route to investigate allergic responses to food allergens. Because mice usually develop oral tolerance and fail to manifest allergic responses to ingested allergens, allergens are frequently co-administered with an adjuvant. However, recent reports indicate that commonly used adjuvants, such as cholera toxin (CT) and alum, possess immune-stimulatory properties that may falsely test non-allergenic food products as positive . Consequently, there is increasing interest to develop adjuvant-free systemic sensitization models for testing food allergenicity in mice. The main objectives of this study were to evaluate probiotic effects of LGG on CMA development in a Balb/C mouse model using either an adjuvant-assisted oral sensitization (CMP with cholera toxin B-subunit, CTB) method or an adjuvant-free systemic sensitization (CMP only) method.
Cow's Milk Proteins
Cow's milk proteins were prepared from fresh milk. Briefly, milk was defatted by centrifuging at 1,000 g for 10 min at 4°C and discarding the upper fat layer . After addition of 12% trichloroacetic acid (TCA) (w⁄v), milk proteins were allowed to precipitate for 2 h at 4°C before centrifuging at 9,300 g for 10 min at 4°C. The supernatant was discarded and equal volume of distilled water was added more than five times to the precipitated whole milk protein to remove excess TCA. The concentrated CMP was then lyophilized and stored at 4°C. CMP's protein content (82.34 ± 0.53%) was verified by the Kjeldahl method whereas the presence of major milk proteins was confirmed by 12% SDS-PAGE gel electrophoresis.
Three weeks-old female Balb/C mice were purchased from Charles River Breeding laboratories (St. Constant, Quebec, Canada). All mice were fed a diet that was free from animal proteins and microbes (Harlan Teklad, Madison, WI, USA). Feed and water were provided ad libitum. Mice were raised in individual cages, and under a 12L:12D lighting cycle, 20-24°C range of ambient temperature and 40-70% of relative humidity. The animal use protocol was approved by the McGill University Animal Care Committee.
Sensitization and Challenge Procedures
Intragastrically Sensitized (Gavage) Group
Intraperitoneally Sensitized (IP) Group
The experimental design for CMP intraperitoneally sensitized group is shown in Figure 1b. There were 4 treatments in the IP group of mice which included CTL-, CTL+, LGG1, and LGG2 similar to the gavage group of mice. At 6 and 7 weeks of age, each mouse in the 4 treatment groups received 2 doses of CMP (10 mg/mouse) dissolved in 250 μl of PBS intraperitoneally. One week after the second IP sensitization, mice were orally challenged with CMP, and blood and spleen samples were collected similar to mice of the gavage group.
Evaluation of Hypersensitivity Symptoms
Within an hour following the final oral CMP challenge, hypersensitivity symptoms were scored by a person blind to the study using the score system as described by Schouten et al. . The scores were as follows: 0 = no symptom; 1 = scratching and rubbing around the nose and head; 2 = reduced activity; 3 = activity after prodding and puffiness around the eyes and mouth; 4 = no activity after prodding, laboured respiration, and cyanosis around the mouth and the tail; and 5 = death.
Determination of Serum CMP-specific (IgG1, IgG2a and IgG) and Total IgE
Blood samples from mice in the gavage and IP groups were collected into serum separator tubes (Sarstedt, Montreal, Quebec, Canada). The serum portion was separated by centrifugation at 10,000 × g for 5 min at 20°C. Serum samples were then aliquoted into eppendorf tubes and stored at -20°C until being analysed. CMP-specific serum immunoglobulins, namely IgG1, IgG2a and IgG as well as total IgE, were detected by ELISA. Briefly, 96-well plates (Dynatech Laboratories, Chantilly, VA) were coated with 100 μg/mL of CMP in 0.1 mol/L Na-bicarbonate/carbonate coating buffer (pH 9.6). After overnight incubation at 4°C, plates were washed 3 times with 150 μl of PBS plus 0.05% Tween-20 (PBS-T) and blocked with 100 μl of 2% fish gelatine (Sigma Aldrich, Ontario, Canada) in PBS-T for 1 h at 37°C. Subsequently, the plates were washed 3 times and 100 μl of serially diluted serum samples (started from1:10 dilutions for IgE, IgG1 and IgG2a and 1:100 for IgG) were added to the wells and incubated at 37°C for 90 min. Plates were then washed 3 times, and 100 μL of horseradish peroxidase (HRP) conjugated anti-mouse antibodies (1:2000 for IgE, IgG1 and IgG2a and 1: 4000 for IgG) were added to each well. The plates were again incubated at 37°C for another 60 min and washed 3 times. Then, 100 μl of ABTS were added to each well and 15 min were allowed for the development of colorimetric reactions. Absorbance was read at a wavelength of 405 nm in a microplate reader (Bio-Tek, Winooski, VT). All analyses were performed in duplicates and the average values were used in the statistical analysis. Serum titres were calculated by the intersection of least square regression of A405 versus logarithm of dilution .
Cytokine Measurements from Spleen Lysates
Spleen lysates were prepared as previously described . Briefly, individual spleens were placed in eppendorf tubes containing 0.5 ml of lysate buffer. The spleen cells were lysed and homogenized by sonication for 30 s on ice. Supernatants were collected after centrifugation at 17,500 g for 10 min at 4°C and stored at -20°C. Interleukin-4 (IL-4) and interferon-gamma (IFN- γ) from spleen lysates were analyzed by commercially available ELISA kits following the manufacturer's protocol (R&D systems, Minneapolis, MN). Total protein content in spleen lysates was determined using the detergent compatible protein assay (Bio-Rad Laboratories Inc., Hercules, CA) and bovine serum albumin as standard. Cytokine concentrations from spleen lysates were expressed as pg/mg of total protein of spleen.
PCR Identification of Fecal Lactobacillus
For PCR analysis, 100 mg of fecal samples were aseptically weighed, placed in sterile tubes and homogenized in 1.4 mL stool lysis buffer (QIAamp DNA stool kit; Qiagen, ON, Canada). Genomic DNA extraction was performed according to the manufacturer's protocol. DNA was then amplified using the Crimson taq DNA Polymerase with Mg-free Buffer, 25 mM MgCl2, 10 mM dNTP and Crimson Taq DNA Polymerase (New England BioLabs, ON, Canada) and Lactobacillus-specific primers. The primer-set sequences were as described previously . PCR reactions were performed at 95°C for 2 min and 95°C for 30 s, followed by 30 cycles of 45 s at 60°C and 68°C for 5 min in an Eppendorf Mastercycler EP Gradient 5341 (Fisher Scientific, ON, Canada). Finally, the presence of lactobacillus strains was detected by performing agarose gel electrophoresis 1% (w/v) with the PCR products and using genomic DNA from pure L. rhamnosus GG (ATCC53103) as control. The PCR amplicons were visualized under UV light (260 nm) followed by a subsequent SafeView nucleic acid staining (0.5 μg/ml; NBS Biologicals, UK).
Enumeration of Fecal Lactobacilli
Lactobacilli counts were determined from fecal samples of IP mice at 16 and 30 d. At 12 h prior to sample collection, mice were transferred to new cages which were lined with moist paper towels instead of the standard rodent bedding. After fecal sample collection into sterile microbiology bags, mice were returned into their respective treatment cages. Sample homogenization, serial dilutions and culture on bacteria-specific agars were as previously described . Briefly, fresh fecal pellets were diluted 10-folds by weight in buffered peptone water, homogenized, and serially diluted in 0.85% sterile saline solution. Lactobacilli were anaerobically cultured on Lactobacilli MRS agar for 24 h at 37°C. Bacterial colonies were counted at the end of incubation period. Microbiological analyses were performed in duplicates and the mean values were used in statistical analyses.
Data were analyzed by a one-way ANOVA using the GLM procedure of SAS (SAS Institute, 2003) except for the hypersensitivity scores data which were analyzed using the Kruskal-Wallis test and SigmaStat software (Systat Software Inc., San Jose, CA). Differences among treatment means were tested using the Scheffe's multiple comparison test. P-values ≤ 0.05 were considered significantly different. Results were presented as mean ± standard deviation. All microbiological concentrations were subjected to base-10 logarithm transformation before analyses.
CMP-specific Immunoglobulin Levels in Serum
Immunoglobulins titres from the sera of IP mice.
71.67 ± 10.75b
74.67 ± 28.62
101.0 ± 9.07a
43.67 ± 14.58
102.17 ± 10.64a
42.67 ± 5.06
112.17 ± 8.76a
79.43 ± 48.21
CMP-specific Immunoglobulin titres from the sera and cytokines level from spleen lysate in Gavage group.
68.17 ± 4.14
35.33 ± 11.35b
9.70 ± 4.64
9.93 ± 0.37b
68.0 ± 6.08
34.83 ± 5.87b
10.22 ± 5.65
13.65 ± 1.42ab
68.50 ± 3.45
59.50 ± 26.44 b
12.42 ± 6.41
15.52 ± 1.39ab
76.83 ± 13.98
131.33 ± 51.39a
11.90 ± 4.60
14.47 ± 3.20ab
69.67 ± 5.62
92.17 ± 37.47ab
8.42 ± 4.66
16.45 ± 2.26a
Cytokine Levels in Spleen Lysates
Cytokines level from spleen lysate of IP mice (pg/mg of total protein).
IFN- γ (pg/mg)*
15.33 ± 4.51
18.33 ± 3.25
19.3 ± 6.36
21.53 ± 5.69
17.35 ± 3.56
26.82 ± 8.02
14.47 ± 5.07
26.3 ± 4.69
Fecal Counts and PCR Analysis of Lactobacilli
Fecal counts of total Lactobacilli from IP group at d 16 and d 30.
9.01 ± 0.08
8.70 ± 0.17b
8.83 ± 0.16
8.89 ± 0.18ab
9.04 ± 0.12
8.86 ± 0.10ab
8.80 ± 0.28
9.03 ± 0.13a
CMA is a global health concern that occurs more frequently among children than adults. In infants, high CMA incidence occurs upon first exposure to CMP, for example through infant formulas, while the immune system is still immature. On the other hand, the intestinal immune-modulating effects of probiotics  have been shown to reduce the risks of developing allergic diseases in both mice [14, 15, 24] and humans [27, 28]. The present study evaluated whether oral LGG administration could help reduce or control CMA in Balb/C mice that were sensitized with CMP either via the oral (gavage) or systemic (IP) route. Moreover, to better simulate CMA in infants, we specifically used 3 week-old newly weaned Balb/C mice as an animal model and whole CMP as allergen rather than purified single CMPs.
In the IP group of mice, both LGG1 and LGG2 groups, in comparison with CTL+ mice, may possibly alleviate allergy as indicated by numerically lower hypersensitivity responses (Figure 2), lower IL-4 levels, and lower CMP-specific IgG1 but higher IFN-γ and CMP-specific IgG2a levels (Figure 3 and Table 3). Generally, an increase in Th2 response in mice results in higher secretions of IL-4, and allergen-specific IgE and IgG1, whereas increasing the Th1 response leads to higher IFN-γ and IgG2a levels . Therefore, together with previous in vitro  and mice [14, 31] studies, our findings suggest that LGG supplementation may alleviate allergic reactions by supressing Th2-mediated immune responses. Similarly, allergy reducing effects by probiotics have been reported in clinical studies [27, 28], in which LGG or a mixture of probiotics containing LGG prevented atopic eczema in high risk infants. The anti-allergic effects of probiotics have also been demonstrated in ovalbumin-induced asthma  and atopic dermatitis NC/Nga mice models . We also observed that an additional week of oral LGG administration between the LGG1 and LGG2 groups of mice did not significantly alter total Lactobacilli counts, hypersensitivity scores, and serum concentrations of IL-4, CMP-specific IgG1 or CMP-specific IgG2a. Therefore, under the conditions of this study, it appears that greater probiotic supplementation beyond 4 time points had no major benefits in alleviating CMA. However, the exact reason is unknown.
Elevated IL-4, allergen-specific IgE and IgG1 are well recognized principal immune mediators of IgE-mediated allergy. Allergen-specific IgE is not easy to be measured when using conventional methods because IgE is generally present at low levels in the serum and its measurement is more complicated by the serum's higher IgG levels. Moreover, it is reported that both CMP-specific IgE and IgG have competitive binding ability to similar epitopes regions of CMP, and that the greater serum IgG levels significantly reduced the binding capacity of serum IgE to CMP . But, in the event that specific IgE is undetectable or non-measurable, IgG1 can be used as a surrogate maker for IgE if it is accompanied by increased IL-4 [34, 35]. Although we were unable to detect CMP-specific IgE, our findings about elevated serum IL-4 together with significantly higher CMP-specific IgG1 in CTL+ mice in comparison with CTL- mice indicate that IgE-mediated allergy may have occurred in CMP-sensitized mice. In agreement with our results, CMP-specific IgE was also undetectable in other mice allergy studies [19, 36]. It appears that serum concentrations of allergen-specific IgE are highly dependent on the type of administered allergen. For instance, when mice were orally sensitized with casein or whey, Schouten et al.  successfully measured whey-specific IgE and IgG1 but could not detect casein-specific IgE. We presume that CMP-specific IgE responses could have been reduced in our study considering the fact that whole CMP contains 20% whey only, but 80% casein. In addition, we suspect that a direct ELISA method used in this study might not have been sensitive enough to detect and measure CMP-specific serum IgE.
Our results about significantly higher hypersensitivity scores and CMP-specific antibodies titres (IgG1, IgG2a and IgG) in CMP-sensitized CTL+ mice with compared to CTL- mice demonstrate that adjuvant-free IP sensitization successfully stimulated CMP-specific immune responses (Figure 2, 3 and Table 1). Therefore, an adjuvant-free systemic sensitization mouse model can well be adopted to study the allergenicity of low allergen-containing foods, considering that adjuvant co-administration may falsely test non-allergic food products as allergic .
We did not observe visible hypersensitivity symptoms and different levels of CMP-specific IgG1 and IgG between CTL+ and CTL- subgroups in orally sensitized (Gavage) mice (Table 2). We have chosen CTB due to its non-toxic adjuvant property and it has been used in food allergy studies [38, 39]. However, it seems that under the conditions of this study, the oral administration of CMP and CTB mixture was not allergenic to mice. In addition to the well-known fact that oral sensitization could induce tolerance development, recent reports indicate that CTB possesses allergy suppressing rather than stimulating effects in mice through induction of secretory IgA . Based on our findings and the above-mentioned report, it seems that CTB may not be an appropriate oral adjuvant that can successfully induce CMP-specific allergic responses in Balb/C mice.
To our knowledge, we are the first to investigate the effects of LGG supplementation on CMA in mice that were sensitized with the whole CMP. We believe that the adjuvant-free systemic sensitization model may be particularly useful in the testing of food products with low allergenicity. LGG administration seems to favour suppression of Th2 responses such as reduced hypersensitivity scores and lowered serum CMP-specific IgG1 while promoting Th1 responses by causing elevated IFN-γ and CMP-specific IgG2a levels. Although further experimental and clinical studies are required to elucidate the mechanism involved and complete beneficial effects of LGG, the current study suggests LGG as a potential preventive tool in the fight against CMA.
This study was supported by funding from Agriculture and Agri-Food Canada to Dr. Joyce I. Boye and James McGill Professorship to Dr. Xin Zhao. We thank Dr. Kwet Fane Ng-Kwai-Hang for his invaluable advice in cow's milk protein preparation.
- Bahna SL: Cow's milk allergy versus cow milk intolerance. Ann Allergy Asthma Immunol. 2002, 89: 56-60.View ArticlePubMedGoogle Scholar
- Sicherer SH, Sampson HA: Food allergy. J Allergy Clin Immunol. 2010, 125: 116-25. 10.1016/j.jaci.2009.09.051.View ArticleGoogle Scholar
- Lee JW, Kim JH, Yook HS, Kang KO, Lee SY, Hwang HJ, Byun MW: Effects of gamma radiation on the allergenic and antigenic properties of milk proteins. J Food Prot. 2001, 64: 272-6.PubMedGoogle Scholar
- Bonomi F, Fiocchi A, Frokiaer H, Gaiaschi A, Iametti S, Poiesi C, Rasmussen P, Restani P, Rovere P: Reduction of immunoreactivity of bovine beta-lactoglobulin upon combined physical and proteolytic treatment. J Dairy Res. 2003, 70: 51-9. 10.1017/S0022029902005678.View ArticlePubMedGoogle Scholar
- Vickery BP, Burks AW: Immunotherapy in the treatment of food allergy: focus on oral tolerance. Curr Opin Allergy Clin Immunol. 2009, 9: 364-70. 10.1097/ACI.0b013e32832d9add.View ArticlePubMedGoogle Scholar
- Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y: The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol. 1997, 159: 1739-45.PubMedGoogle Scholar
- Hazebrouck S, Przybylski-Nicaise L, Ah-Leung S, Adel-Patient K, Corthier G, Wal JM, Rabot S: Allergic sensitization to bovine beta-lactoglobulin: comparison between germ-free and conventional BALB/c mice. Int Arch Allergy Immunol. 2009, 148: 65-72. 10.1159/000151507.View ArticlePubMedGoogle Scholar
- Martinez FD, Holt PG: Role of microbial burden in aetiology of allergy and asthma. Lancet. 1999, 354: 12-15.View ArticleGoogle Scholar
- Kalliomaki M, Isolauri E: Role of intestinal flora in the development of allergy. Curr Opin Allergy Clin Immunol. 2003, 3: 15-20. 10.1097/00130832-200302000-00003.View ArticlePubMedGoogle Scholar
- Adlerberth I, Wold AE: Establishment of the gut microbiota in Western infants. Acta Paediatr. 2009, 98: 229-38. 10.1111/j.1651-2227.2008.01060.x.View ArticlePubMedGoogle Scholar
- Strachan DP: Hay fever, hygiene, and household size. BMJ. 1989, 299: 1259-60. 10.1136/bmj.299.6710.1259.PubMed CentralView ArticlePubMedGoogle Scholar
- Bjorksten B, Sepp E, Julge K, Voor T, Mikelsaar M: Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol. 2001, 108: 516-20. 10.1067/mai.2001.118130.View ArticlePubMedGoogle Scholar
- Sepp E, Julge K, Mikelsaar M, Bjorksten B: Intestinal microbiota and immunoglobulin E responses in 5-year-old Estonian children. Clin Exp Allergy. 2005, 35: 1141-6. 10.1111/j.1365-2222.2005.02315.x.View ArticlePubMedGoogle Scholar
- Shida K, Takahashi R, Iwadate E, Takamizawa K, Yasui H, Sato T, Habu S, Hachimura S, Kaminogawa S: Lactobacillus casei strain Shirota suppresses serum immunoglobulin E and immunoglobulin G1 responses and systemic anaphylaxis in a food allergy model. Clin Exp Allergy. 2002, 32: 563-70. 10.1046/j.0954-7894.2002.01354.x.View ArticlePubMedGoogle Scholar
- Hougee S, Vriesema AJ, Wijering SC, Knippels LM, Folkerts G, Nijkamp FP, Knol J, Garssen J: Oral treatment with probiotics reduces allergic symptoms in ovalbumin-sensitized mice: a bacterial strain comparative study. Int Arch Allergy Immunol. 2010, 151: 107-17. 10.1159/000236000.View ArticlePubMedGoogle Scholar
- Gonipeta B, Parvataneni S, Tempelman RJ, Gangur V: An adjuvant -free mouse model to evaluate the allergenicity of milk whey protein. J Dairy Sci. 2009, 92: 4738-44. 10.3168/jds.2008-1927.View ArticlePubMedGoogle Scholar
- Romagnani S: Type 1 T helper and type 2 T helper cells: functions, regulation and role in protection and disease. Int J Clin Lab Res. 1991, 21: 152-8.View ArticlePubMedGoogle Scholar
- Dearman RJ, Kimber I: Animal models of protein allergenicity: potential benefits, pitfalls and challenges. Clin Exp Allergy. 2009, 39: 458-68. 10.1111/j.1365-2222.2008.03194.x.View ArticlePubMedGoogle Scholar
- Lara-Villoslada F, Olivares M, Jimenez J, Boza J, Xaus J: Goat milk is less immunogenic than cow milk in a murine model of atopy. J Pediatr Gastroenterol Nutr. 2004, 39: 354-60. 10.1097/00005176-200410000-00010.View ArticlePubMedGoogle Scholar
- Gill HS, Rutherfurd KJ: Viability and dose-response studies on the effects of the immunoenhancing lactic acid bacterium Lactobacillus rhamnosus in mice. Br J Nutr. 2001, 86: 285-9. 10.1079/BJN2001402.View ArticlePubMedGoogle Scholar
- Schouten B, van Esch BC, Hofman GA, van Doorn SA, Knol J, Nauta AJ, Garssen J, Willemsen LE, Knippels LM: Cow Milk Allergy Symptoms Are Reduced in Mice Fed Dietary Synbiotics during Oral Sensitization with Whey. J Nutr. 2009, 139: 1398-403. 10.3945/jn.109.108514.View ArticlePubMedGoogle Scholar
- Kerro-Dego O, Prysliak T, Potter AA, Perez-Casal J: DNA-protein immunization against the GapB and GapC proteins of a mastitis isolate of Staphylococcus aureus. Vet Immunol Immonopathol. 2006, 113: 125-38. 10.1016/j.vetimm.2006.04.004.View ArticleGoogle Scholar
- Alkan SS, Akdis AC, Feuerlein D, Gruninger M: Direct measurement of cytokines (IFN-gamma, IL-4, -5, and -6) from organs after antigenic challenge. Ann N Y Acad Sci. 1996, 796: 82-90. 10.1111/j.1749-6632.1996.tb32569.x.View ArticlePubMedGoogle Scholar
- Blumer N, Sel S, Virna S, Patrascan CC, Zimmermann S, Herz U, Renz H, Garn H: Perinatal maternal application of Lactobacillus rhamnosus GG suppresses allergic airway inflammation in mouse offspring. Clin Exp Allergy. 2007, 37: 348-57. 10.1111/j.1365-2222.2007.02671.x.View ArticlePubMedGoogle Scholar
- Baurhoo B, Letellier A, Zhao X, Ruiz-Feria CA: Cecal populations of Lactobacilli and Bifidobacteria and Escherichia coli populations after in vivo Escherichia coli challenge in birds fed diets with purified Lignin or Mannanoligosaccharides. Poult Sci. 2007, 86: 2509-16. 10.3382/ps.2007-00136.View ArticlePubMedGoogle Scholar
- Savilahti E, Kuitunen M, Vaarala O: Pre and probiotics in the prevention and treatment of food allergy. Curr Opin Allergy Clin Immunol. 2008, 8: 243-248. 10.1097/ACI.0b013e3282ffb134.View ArticlePubMedGoogle Scholar
- Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E: Probiotics in primary prevention of atopic disease: a randomised placebo controlled trial. Lancet. 2001, 357: 1076-9. 10.1016/S0140-6736(00)04259-8.View ArticlePubMedGoogle Scholar
- Kukkonen K, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Kuitunen M: Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2007, 119: 192-8. 10.1016/j.jaci.2006.09.009.View ArticlePubMedGoogle Scholar
- Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 2005, 75: 5-14.Google Scholar
- Pochard P, Gosset P, Grangette C, Andre C, Tonnel AB, Pestel J, Mercenier A: Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients. J Allergy Clin Immunol. 2002, 110: 617-23. 10.1067/mai.2002.128528.View ArticlePubMedGoogle Scholar
- Kim JY, Choi YO, Ji GE: Effect of oral probiotics (Bifidobacterium lactis AD011 and Lactobacillus acidophilus AD031) administration on ovalbumin-induced food allergy mouse model. J Microbiol Biotechnol. 2008, 18: 1393-400.PubMedGoogle Scholar
- Sawada J, Morita H, Tanaka A, Salminen S, He F, Matsuda H: Ingestion of heat-treated Lactobacillus rhamnosus GG prevents development of atopic dermatitis in NC/Nga mice. Clin Exp Allergy. 2007, 37: 296-303. 10.1111/j.1365-2222.2006.02645.x.View ArticlePubMedGoogle Scholar
- Lehrer SB, Reish R, Fernandes J, Gaudry P, Dai G, Reese G: Enhancement of murine IgE antibody detection by IgG removal. J Immunol Methods. 2004, 284: 1-6. 10.1016/j.jim.2003.08.017.View ArticlePubMedGoogle Scholar
- Miyajima I, Dombrowicz D, Martin TR, Ravetch JV, Kinet JP, Galli SJ: Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and FcgRIII: assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG-dependent passive anaphylaxis. J Clin Invest. 1997, 99: 901-14. 10.1172/JCI119255.PubMed CentralView ArticlePubMedGoogle Scholar
- Faquim-Mauro EL, Coffman RL, Abrahamsohn IA, Macedo MS: Mouse IgG1 antibodies comprise two functionally distinct types that are differentially regulated by IL-4 and IL-12. J Immunol. 1999, 163: 3572-6.PubMedGoogle Scholar
- Lara-Villoslada F, Olivares M, Xaus J: The balance between caseins and whey proteins in cow's milk determines its allergenicity. J Dairy Sci. 2005, 88: 1654-60. 10.3168/jds.S0022-0302(05)72837-X.View ArticlePubMedGoogle Scholar
- Schouten B, van Esch BC, Hofman GA, van den Elsen LW, Willemsen LE, Garssen J: Acute allergic skin reactions and intestinal contractility changes in mice orally sensitized against casein or whey. Int Arch Allergy Immunol. 2008, 147: 125-34. 10.1159/000135699.View ArticlePubMedGoogle Scholar
- Spangler BD: Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol Rev. 1992, 56: 622-47.PubMed CentralPubMedGoogle Scholar
- Untersmayr E, Jensen-Jarolim E: Mechanisms of type I food allergy. Pharmacol Ther. 2006, 112: 787-98. 10.1016/j.pharmthera.2006.06.004.View ArticlePubMedGoogle Scholar
- Smits HH, Gloudemans AK, van Nimwegen M, Willart MA, Soullié T, Muskens F, de Jong EC, Boon L, Pilette C, Johansen FE, Hoogsteden HC, Hammad H, Lambrecht BN: Cholera toxin B suppresses allergic inflammation through induction of secretory IgA. Mucosal Immunol. 2009, 2: 331-9. 10.1038/mi.2009.16.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.